KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) Operating Expenses (2016 - 2026)

Staar Surgical's Operating Expenses history spans 17 years, with the latest figure at $75.8 million for Q1 2026.

  • For Q1 2026, Operating Expenses rose 143.69% year-over-year to $75.8 million; the TTM value through Jan 2026 reached $274.7 million, up 24.22%, while the annual FY2026 figure was $314.2 million, 132.36% up from the prior year.
  • Operating Expenses reached $75.8 million in Q1 2026 per STAA's latest filing, up from $68.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $149.4 million in Q4 2022 to a low of $19.9 million in Q2 2022.
  • Average Operating Expenses over 5 years is $58.4 million, with a median of $55.9 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: soared 220.13% in 2022, then crashed 84.07% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $149.4 million in 2022, then crashed by 84.07% to $23.8 million in 2023, then surged by 30.73% to $31.1 million in 2024, then soared by 120.45% to $68.6 million in 2025, then grew by 10.54% to $75.8 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Operating Expenses are $75.8 million (Q1 2026), $68.6 million (Q3 2025), and $31.2 million (Q2 2025).